Innovacell Inc.

504A TSE Pharmaceuticals Pharmaceutical
TSE Growth

Shareholding pattern

As reported in the annual securities report, 2025-12-31.

Foreign institutions28.78%
Individuals28.65%
Top 10 holders64.05%
Total shareholders181

Who owns the company

Share of voting units
Foreign institutions: 28.78%Individuals & others: 28.65%Other corporations: 28.63%Foreign individuals: 13.94%28.8%Foreign institutions
Foreign institutions 28.78%Individuals & others 28.65%Other corporations 28.63%Foreign individuals 13.94%

How to read this: each slice is a group of investors. Foreign and financial institutions are professional money; individuals are retail shareholders; other corporations are usually business partners holding strategic stakes. A large institutional slice generally means heavier analyst coverage and more trading volume.

Ownership detail

Investor categoryHolding %Shareholders
Foreign institutions28.78%9
Individuals & others28.65%122
Other corporations28.63%36
Foreign individuals13.94%14

How to read this: a high foreign or institutional share often means the stock is widely researched and more liquid; a high individual share means retail investors hold most of the company. Percentages are of voting units.

Largest shareholders

S.No.ShareholderSharesStake %
1Peppermint Grove Limited3,609,81510.83%
2INSANNA Stiftung3,607,98810.82%
3シーズ・インベストメント有限責任事業組合2,464,1007.39%
4ノビック・コーリン2,291,7216.87%
5シーガー・ジェイソン2,291,7216.87%
6マークシュタイナー・ライナー2,140,6286.42%
7坂野 敦1,643,9144.93%
8Glymur Biotech Ventures LP1,339,5084.02%
9アルフレッサ株式会社1,176,4713.53%
10山田 敏治791,7002.37%

Trust banks such as Master Trust and Custody Bank appear at the top of most Japanese registers: they hold shares on behalf of many underlying funds rather than owning them outright.

Educational data only. Not a recommendation to buy, sell or hold any security.